Tag Archives: Federal Circuit

Supreme Court Asks Government To Weigh In On Saint-Gobain’s Cert. Request

Posted on November 9, 2011 by Warren Woessner

Since I have done two, rather lengthy posts on the Fed. Cir. split decision in Siemens Med. Solutions USA, Inc. v. Saint-Gobain Ceramics & Plastics, 637 F.3d 1269 (Fed. Cir. 2011) , reh’g den. 647 F.3d 1373 (2011), it deserves … Continue reading →

Posted in Doctrine of Equivalents | Tagged , , , | Leave a comment

Mayo’s Brief Goes Back To A (Non-Precedential) Future

Posted on November 3, 2011 by Warren Woessner

You all may be suffering from Prometheus v. Mayo fatigue by now, but this remains the most important IP case before the Supreme Court, and may well alter the course of life sciences patenting for the foreseeable future. I know … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 1 Comment

Infringement by Unobvious Changes – A Look (Way) Back

Posted on October 16, 2011 by Warren Woessner

As a much younger attorney, I gave a presentation at the 1990 AIPLA Annual Meeting:  “A Review of Recent Federal Circuit Decisions Relating to Infringement” (AIPLA Selected Legal Papers, 9, 3 (July 1991)), in which I wrestled with the question … Continue reading →

Posted in Doctrine of Equivalents, Infringement | Tagged , , , , , , , , , , , , | Leave a comment

Obviousness = Equivalence? Saint-Gobain v. Siemens

Posted on October 14, 2011 by Warren Woessner

Saint-Gobain Ceramics (“S-G”) has asked the Supreme Court to review the Fed. Cir. panel below, 647 F.3d 1373 (Fed. Cir. 2011) in which the panel decision refused to reverse a district court decision that instructed the jury that it could … Continue reading →

Posted in Doctrine of Equivalents | Tagged , , , , , , , , , , , , , , | 1 Comment